During consultation, your doctor will check your previous medical records and take a detailed history to assess your suitability for treatment
Neither medication requires refrigeration after the first use, making them convenient for patients managing their treatment options at home
In small proof-of-concept phase 2 randomized controlled trials (RCTs) in patients with biopsy-confirmed MASH, liraglutide at 1.8 mg/day for 48 weeks (201), semaglutide at 0.4 mg/day for 72 weeks (202), and tirzepatide at 15 mg/week for 52 weeks (203) have been reported to achieve placebo-corrected percentages of participants meeting the criteria for resolution of MASH without worsening fibrosis by 30% (P = 0.019), 42% (P 10%) may lead to diabetes remission (237)
Ozempics proven track record and current accessibility make it the practical choice for those ready to start treatment
Over a year, brand-name semaglutide costs $11,600 to $16,200 out of pocket
Why PatchAid